CN113413355B - Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof - Google Patents

Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof Download PDF

Info

Publication number
CN113413355B
CN113413355B CN202110771890.6A CN202110771890A CN113413355B CN 113413355 B CN113413355 B CN 113413355B CN 202110771890 A CN202110771890 A CN 202110771890A CN 113413355 B CN113413355 B CN 113413355B
Authority
CN
China
Prior art keywords
phase
mixture
brightening
eye cream
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110771890.6A
Other languages
Chinese (zh)
Other versions
CN113413355A (en
Inventor
夏有章
周道年
张卫平
孙金龙
谈畅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ma Yinglong Health Co ltd
Original Assignee
Ma Yinglong Health Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ma Yinglong Health Co ltd filed Critical Ma Yinglong Health Co ltd
Priority to CN202110771890.6A priority Critical patent/CN113413355B/en
Publication of CN113413355A publication Critical patent/CN113413355A/en
Application granted granted Critical
Publication of CN113413355B publication Critical patent/CN113413355B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses an eye cream with an instant brightening and wrinkle-reducing effect and a preparation method thereof, wherein the eye cream with the instant brightening and wrinkle-reducing effect comprises an instant brightening component, an instant wrinkle-reducing component, other active substances, glycerin, propylene glycol, butanediol, EDTA disodium, polydimethylsiloxane, PMX-1503 silicone oil, phenyl trimethicone, MONTANOV68 and SIMULS0L165 emulsifying agents, sodium surfactin, SEPINOV EMT10 thickening agent, polysorbate-20, 1, 2-hexanediol, p-hydroxyacetophenone, deionized water and the like. The eye cream with the effect of immediately brightening and line lightening, which is prepared by the invention, has the effects of immediately brightening and filling wrinkles, is multi-dimensional and skin-beautifying, is uniform in product particles, good in hand feeling and better in market sales prospect.

Description

Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof
Technical Field
The invention belongs to the technical field of skin care products, and particularly relates to eye cream with an instant wrinkle brightening and lightening effect and a preparation method thereof.
Background
The problem of the skin around the eyes, which affects the appearance of the eyes and shows aging, often begins with the first obvious wrinkles on the eyes. The aging of the eye periphery, especially, the factors affecting the beauty. The main current nursing means in the market for aging and skin beautification are as follows: (1) injecting filler to strengthen collagen and elastin matrix, and filling skin; (2) endotoxin is injected to inhibit muscle contraction and immediately remove wrinkles; (3) lifting the ultrasonic knife to remove wrinkles and tighten and age the skin instantly; (4) smearing and filling, and physically covering fine lines to achieve instant light lines in vision; (5) supplementing water, strengthening moisture-keeping nursing, and relieving dry wrinkles.
In the prior art, patent document CN112891290A discloses an eye cream with an eye corner brightening effect, and patent document CN109864909A discloses a wrinkle-reducing eye cream, but the eye creams in the patent documents only have the wrinkle-reducing or brightening effect and do not have a compound effect. After investigation and retrieval, the applicant finds that the skin care products with the functions of instant brightening and instant light streaking are rarely available on the market at present, the action mechanism of the existing skin care products on the market is single, and how to perform multi-dimensional skin care from five directions in the above care means to meet the demand of instant skin beautification is an urgent problem to be solved in the prior art.
Meanwhile, how to effectively solve the problems of uneven emulsification and uneven particles caused by mixing of different components is also a major technical problem in the product development process.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide the eye cream with the effect of immediately brightening and lightening the wrinkles, the effect of immediately beautifying the skin is achieved by performing multidimensional skin care, and the obtained eye cream is fine and smooth in hand feeling, strong in silky feeling and stable in property.
The invention also aims to provide a preparation method of the eye cream, which is characterized in that the eye cream product prepared by scientifically preparing and mixing the substances in a split-phase manner has good properties and a simple preparation process.
In order to achieve the purpose, the invention adopts the following technical scheme:
an eye cream with an instant brightening and wrinkle reducing effect comprises the following preparation raw materials in parts by weight:
Figure BDA0003153941560000011
Figure BDA0003153941560000021
according to the eye cream with the effect of immediately brightening and line lightening, the surfactin sodium contained in the raw materials can reduce irritation, resist inflammation and improve skin permeability, and the eye cream not only has excellent moisture retention capacity, antibacterial and bacteriolytic effects and fine line lightening effect, but also is a strong biological emulsifier and a strong dispersing agent, assists in dispersing powder and enhances the stability of a formula.
The invention provides an eye cream with the efficacy of immediately brightening and lightening wrinkles, which is prepared by dissolving a PMX-1503 silicone oil into an organic silicon elastomer. The PMX-1503 silicone oil not only can excellently disperse the organic silicon elastomer in the instant wrinkle-reducing component, but also can help to form a film on the surface of skin, so that the silky feeling of the product is increased, and the instant wrinkle-reducing effect of the eye cream is further enhanced.
Preferably, the instant lightening component is a silver pearlescent pigment comprised of a multilayer platelet structure comprising particles of a synthetic mica substrate coated with inorganic and/or organic pigments, preferably a synthetic mica substrate coated with titanium dioxide and tin oxide.
As a further preferred embodiment of the present invention, the instant lightening component is preferably
Figure BDA0003153941560000022
The particle size of the Halo White is smaller and is only 1-15 mu m, and the Halo White is easier to disperse uniformly, so that the prepared product has finer hand feeling.
The instant lightening component selected by the invention
Figure BDA0003153941560000023
The Halo White comprises synthetic fluorophlogopite, titanium dioxide and tin oxide, the composition of the Halo White has a silvery White superfine effect, the pigment can generate super-feeling luster on the skin due to pure chroma, the pigment has aesthetic appeal in a formula, and the effects of brightening the skin color, physically covering fine lines and brightening light lines in real time visually are achieved.
Preferably, the instant light grain component comprises 0.01-1 part by weight of acetylated sodium hyaluronate, 0.1-5 parts by weight of acetyl octapeptide-3, 1-5 parts by weight of 4D hyaluronic acid, 0.1-3 parts by weight of gleditsia sinensis seed extract and 1-10 parts by weight of organic silicon elastomer.
As a further preferred embodiment of the invention, the silicone Elastomer is selected from 9576Smooth Away Elastomer.
The instant light line component 9576Smooth Away Elastomer selected by the invention comprises polydimethylsiloxane, polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer, beeswax, silica and silica silylate, and the high molecular silicone Elastomer, the volatile polydimethylsiloxane, the beeswax and the Elastomer powder which are balanced in proportion achieve the purposes of astringing pores, covering fine lines and wrinkles, optically blurring/soft focusing, improving self-photographing beauty, simultaneously having Smooth and sensible feeling, bringing unique texture of instant Smooth skin wrinkles, and achieving the purpose of covering the fine lines by smearing and filling.
The instant wrinkle-removing cream disclosed by the invention is characterized in that acetylated sodium hyaluronate is selected as an instant wrinkle-removing component, sodium hyaluronate subjected to full acetylation treatment can penetrate deeper skin than standard hyaluronic acid, the effect of quickly removing wrinkles can be achieved, and 4D hyaluronic acid is used as a supplement, contains hyaluronic acid with different molecular weights, replenishes water from inside to outside, moisturizes, penetrates deeply, moisturizes and fills the skin, and instantly relieves dry wrinkles.
The instant wrinkle-reducing component of the invention is acetyl octapeptide-3, and is supplemented with skin-care agent, so that the instant wrinkle-reducing component comprises acetyl hexapeptide-8, tripeptide-1 and pentapeptide-3. The acetyl octapeptide-3 is a botulinum toxin mechanism, inhibits excessive release of catecholamine and acetylcholine (acetylcholine) of skin by inhibiting synthesis of SNARE receptors, locally blocks nerve transmission muscle contraction information, relaxes facial muscles, achieves the aim of smoothing fine lines, reduces the depth of wrinkles caused by facial expression muscle contraction, particularly around forehead and eyes, inhibits muscle contraction, and immediately fades wrinkles.
The instant wrinkle-lightening component of the invention is a gleditsia sinensis (GLEDITSIA SINENSIS) seed extract which is a polysaccharide structure and can form a three-dimensional biological polymerization network structure on the surface of skin, mechanically and immediately stretch and tighten the skin, instantly reduce the appearance of wrinkles and fine lines, and instantly tighten and age the skin by lifting and removing the wrinkles.
Preferably, the emulsifier is one or two of SIMULSOL165 and MONTANOV 68.
Preferably, the other active substances comprise, by weight, 0.1-5 parts of nicotinamide, 0.001-0.1 part of borneol, 0.01-1 part of pearl extract, 0.01-0.2 part of ligusticum wallichii root extract, 0.001-0.1 part of poria cocos sclerotium extract, 0.001-0.1 part of rhizoma atractylodis macrocephalae root extract, 0.001-0.5 part of rhizoma bletillae extract, 0.001-0.1 part of radix ampelopsis extract, 0.0001-0.002 part of artificial bezoar and 1-10 parts of rosa damascena flower water.
The active substances of the invention comprise borneol, pearl extract, chuanxiong rhizome extract, poria cocos sclerotium extract, bighead atractylodes rhizome extract, bletilla extract, ampelopsis japonica root extract and calculus bovis factitius. Borneol, pearl and two medicinal materials are applied in the ancient prescription for whitening and removing somberness, which shows that the borneol and pearl medicinal materials have the functions of whitening and removing somberness; modern researches show that the bezoar has a certain antioxidant function and has a certain effect of whitening skin; the common bletilla pseudobulb, the ampelopsis japonica, the bighead atractylodes rhizome and the poria cocos are not only core medicines of the external beautifying famous formula seven-white ointment, but also the most common medicines in a whitening and dark-removing prescription; rhizoma ligustici wallichii is not a medicinal composition of the seven-white ointment, but is also very commonly used in whitening and dark removing formulas; modern researches show that the bletilla striata, the poria cocos and the ligusticum wallichii have multiple functions of whitening, oxidation resistance and the like, and have exact effects on skin whitening.
The active matter of the invention also contains nicotinamide, which can reduce and prevent dark and yellow skin color generated in the early aging process of the skin, repair the stratum corneum lipid barrier of hand cream and improve the skin resistance; meanwhile, the tea also has the effects of deep water locking and moisturizing. On the basis of the technology of the technical scheme, the eye cream with the effect of immediately brightening and line lightening comprises the following raw materials in parts by weight:
Figure BDA0003153941560000041
Figure BDA0003153941560000051
on the basis of the technical scheme, preferably, the preparation raw materials also comprise 1-5 parts of Suyijia.
On the basis of the technical scheme, preferably, the preparation raw materials further comprise 0.1-5 parts of a skin-care agent.
On the basis of the technical scheme, the preferable preparation raw materials further comprise 0.1-1 part of preservative and 0.001-0.1 part of essential oil.
On the basis of the technical scheme, the use of the preservative is not specifically limited, and the preservative is selected from skin care product preservatives commonly used by the technicians in the field, and can be selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol and M-chlorphenesin.
On the basis of the technical scheme, the invention does not specifically limit the use of the essential oil, and the essential oil is selected from skin care essential oils commonly used by the technicians in the field, for example, the essential oil can be selected from one or more of common geranium essential oil and lavender essential oil.
The invention also claims a preparation method of the eye cream with the effect of immediately brightening and lightening wrinkles, which comprises the following steps:
s1, adding glycerol, EDTA disodium, Sumingjia, 4D hyaluronic acid, p-hydroxyacetophenone, 1, 2-hexanediol and sodium surfactin into deionized water, heating to 75-85 ℃, and preserving heat for 5-30min to obtain a mixture A1 phase;
s2, adding the pearl extract, the ligusticum wallichii root extract, the poria cocos sclerotium extract, the bighead atractylodes rhizome root extract, the bletilla striata extract, the radix ampelopsis extract and the polysorbate-20 into deionized water, then adding propylene glycol with borneol and calculus bovis factitius dissolved in the deionized water, heating and dispersing the mixture uniformly, and then sieving the mixture through a 200-mesh sieve to obtain a mixture A2 phase;
s3, adding the mixture A2 phase into the mixture A1 phase, uniformly stirring to obtain a mixture A phase, and preserving heat at 75-85 ℃;
s4, dispersing the organic silicon elastomer by PMX-1503 silicone oil in advance until no particles exist to obtain a mixture B1 phase;
s5, uniformly mixing polydimethylsiloxane, phenyl trimethicone and an emulsifier, heating to 75-85 ℃ to obtain a B2 phase, adding the B1 phase of the mixture obtained in the step S4, uniformly stirring, and keeping the temperature for 5-30min to obtain a B phase of the mixture;
s6, dispersing SEPINOV EMT10 thickening agent with butanediol at room temperature to obtain mixture C phase;
s7, uniformly dispersing the instant brightening component at room temperature by using the residual butanediol in the formula to obtain a mixture D phase;
s8, dissolving acetyl octapeptide-3, skin-friendly agent, nicotinamide, Rosa damascena flower water, Gleditsia sinensis seed extract and sodium hyaluronate with deionized water at room temperature to obtain mixture phase E;
s9, adding the mixture B phase after heat preservation into the mixture A phase, adding the mixture C phase at the same time, keeping the temperature at 75-85 ℃, vacuumizing, keeping high-speed homogenizing and stirring for 5-30min, and obtaining a first mixed phase;
s10, cooling the first mixed phase obtained in the step S9 to 50-60 ℃, adding the mixture D phase obtained in the step S7, and keeping high-speed homogenizing and stirring for 1-30 min to obtain a second mixed phase;
s11, cooling the second mixed phase obtained in the step S10 to 40-50 ℃, adding the phase E of the mixture obtained in the step S8, and keeping high-speed homogenizing and stirring for 1-30 min to obtain a third mixed phase;
s12, cooling the third mixed phase obtained in the step S11 to be below 40 ℃, adding a preservative, a pH regulator and essential oil, regulating the pH to be 5.5-7.5, and stirring for 10-30 min to obtain the eye cream with the effect of immediately brightening and lightening wrinkles.
Preferably, the pH regulator is one or two of citric acid or aminomethyl propanol.
Compared with the prior art, the invention has the following beneficial effects:
according to the invention, by researching the types of the emulsifier and the raw materials, the components are perfectly fused, and the prepared product has fine hand feeling, no granular feeling and good emulsifying effect, so that the eye cream with the effect of instantly brightening and lightening the wrinkles is provided, the skin around the eyes can be beautified and improved more safely and comprehensively, and the effect of instantly brightening and lightening the wrinkles can be achieved by multiple target point designs such as basic moisturizing, deep moisturizing, smoothing and smoothing, lifting and tightening, muscle contraction inhibition, smearing and filling, brightening and soft focus, and the like, and the skin beautification with multiple dimensions can be realized.
In a word, the eye cream provided by the invention has a good effect of immediately brightening and lightening the lines, is exquisite in raw material component selection, good in product character and good in skin beautifying effect, effectively solves the problems of non-uniform emulsification and non-uniform particles caused by mixing of different components, and has a good market application prospect.
Drawings
FIG. 1 is a graph showing a comparison of the effects of 9576 smoothened Away Elastomer dissolution in different solvents. FIG. 1 (1) shows the effect of a 9576Smooth Away Elastomer dispersed in cyclomethicone for 3 min; FIG. 1 (2) shows the dispersing effect of 9576Smooth Away Elastomer dispersed in PMX-1503 silicone oil for 3 min.
FIG. 2 is a schematic representation of the products obtained in example 4 and comparative example 4.
Fig. 3 is a graph comparing the periocular effects of the eye cream prepared in example 4. The left diagram (1) shows the effect before use, and the right diagram (2) shows the effect after use.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
All commodities are purchased through market channels unless specially stated.
Example 1
An eye cream with the efficacy of immediately brightening and lightening wrinkles is prepared by the following raw materials in the following table 1:
table 1 composition of raw materials in example 1
Figure BDA0003153941560000071
Figure BDA0003153941560000081
In this embodiment, the preparation method of the eye cream is as follows:
s1, adding glycerol, EDTA disodium, Sumingjia, 4D hyaluronic acid, p-hydroxyacetophenone, 1, 2-hexanediol and sodium surfactin into deionized water, heating to 80 ℃, and keeping the temperature for 30min to obtain a mixture A1 phase;
s2, adding the pearl extract, the ligusticum wallichii root extract, the poria cocos sclerotium extract, the bighead atractylodes rhizome root extract, the bletilla striata extract, the radix ampelopsis extract and the polysorbate-20 into deionized water, then adding propylene glycol with borneol and calculus bovis factitius dissolved in the deionized water, heating and dispersing the mixture uniformly, and then sieving the mixture through a 200-mesh sieve to obtain a mixture A2 phase;
s3, adding the mixture A2 phase into the mixture A1 phase, uniformly stirring to obtain a mixture A phase, and preserving heat at 75 ℃;
s4, dispersing the organic silicon elastomer by PMX-1503 silicone oil in advance until no particles exist to obtain a mixture B1 phase;
s5, uniformly mixing polydimethylsiloxane, phenyl trimethicone, SIMULSOL165 emulsifier and MONTANOV68 emulsifier, heating to 80 ℃ to obtain a B2 phase, adding the B1 phase of the mixture obtained in the step S4, uniformly stirring, and keeping the temperature for 20min to obtain a B phase of the mixture;
s6, dispersing the SEPINOV EMT10 thickening agent with butanediol at room temperature to obtain a mixture C phase;
s7, uniformly dispersing the instant brightening component at room temperature by using the residual butanediol in the formula to obtain a mixture D phase;
s8, dissolving acetyl octapeptide-3, skin-friendly agent, nicotinamide, Rosa damascena flower water, Gleditsia sinensis seed extract and sodium hyaluronate with deionized water at room temperature to obtain mixture phase E;
s9, adding the mixture B phase after heat preservation into the mixture A phase, adding the mixture C phase at the same time, keeping the temperature at 80 ℃, vacuumizing, keeping the speed at 2500rpm, homogenizing and stirring for 15min to obtain a first mixed phase;
s10, cooling the first mixed phase obtained in the step S9 to 55 ℃, adding the mixture D phase obtained in the step S7, and keeping high-speed homogenizing and stirring for 15min to obtain a second mixed phase;
s11, cooling the second mixed phase obtained in the step S10 to 45 ℃, adding the mixture E phase obtained in the step S8, and keeping 2800rpm for homogenizing and stirring for 15min to obtain a third mixed phase;
s12, cooling the third mixed phase obtained in the step S11 to be below 40 ℃, adding methyl hydroxybenzoate, citric acid and geranium essential oil, adjusting the pH value to 6.0, and stirring for 30min to obtain the eye cream with the effect of immediately brightening and lightening wrinkles.
In the present embodiment, the first and second electrodes are,
Figure BDA0003153941560000082
the particle size of the Halo White is smaller and is only 1-15 μm, and the Halo White is easier to disperse uniformly, so that the prepared product has finer hand feeling, and the product is composed of the following components: 70 wt% of synthetic fluorophlogopite, 29 wt% of titanium dioxide and 1 wt% of tin oxide.
In this example, the 4D hyaluronic acid product was composed of: 0.5 wt% of sodium hyaluronate cross-linked polymer, 1 wt% of sodium hyaluronate, 1 wt% of acetylated sodium hyaluronate, 0.2 wt% of hydrolyzed sodium hyaluronate, 4 wt% of 1, 2-pentanediol, 0.1 wt% of ethylhexyl glycerol, and 93.2 wt% of water.
In this example, 9576Smooth Away Elastomer product was composed of: 85% by weight of polydimethylsiloxane, 5% by weight of polydimethylsiloxane/vinyl polydimethylsiloxane crosspolymer, 5% by weight of polydimethylsiloxane crosspolymer, 4.5% by weight of beeswax, 0.3% by weight of silica, 0.2% by weight of silica silylate.
In this example, the silicone oil PMX-1503 is sold under the name XIAMETER PMX-1503 Fluid, which is a mixture of silicone oil and silica gel, specifically a mixture of ultra-high molecular weight dimethicone alcohol and low viscosity dimethicone.
In this example, the MONTANOV68 emulsifier was a mixture of 80 wt% cetearyl alcohol and 20 wt% cetearyl glucoxib; the SIMULSOL165 emulsifier is a mixture of 50 wt% of glyceryl stearate and 50 wt% of PEG-100 stearate.
In this example, the product of SEPINOV EMT10 thickener was composed of: 85 wt% hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 5.5 wt% polysorbate-60, 5.5 wt% sorbitan isostearate and 4 wt% water.
Examples 2 to 5
Examples 2 to 5 also provide an eye cream with an instant brightening and wrinkle-reducing effect, the preparation raw materials are as shown in table 2 below:
TABLE 2 raw material compositions in examples 2 to 5
Figure BDA0003153941560000091
Figure BDA0003153941560000101
Except for the difference in the amount, the compositions of the components of the eye creams and the preparation method thereof in examples 2 to 5 are the same as those in example 1. Fig. 2 is a schematic view of the eye cream product prepared in example 4.
Comparative example 1
Comparative example 1 does not contain any comparison with example 4
Figure BDA0003153941560000102
And (3) correspondingly omitting the step S7 in the preparation process of the Halo White, adjusting the corresponding steps, and keeping the components of other raw materials and the preparation steps consistent.
Comparative example 2
Compared with the example 4, the 9576Smooth Away Elastomer and the PMX-1503 silicone oil are not contained in the comparative example 2, the step S4 is correspondingly omitted in the preparation process, the corresponding steps are adjusted, and other raw material components and the preparation steps are consistent.
Comparative example 3
Compared with the example 4, the PMX-1503 silicone oil is not contained in the comparative example 3, and the 9576Smooth Away Elastomer is directly used as the B1 phase in the step S4, and the corresponding steps are adjusted, and other steps are basically consistent.
Comparative example 4
Compared with example 4, in comparative example 4, the PMX-1503 silicone oil is replaced by the cyclomethicone, the corresponding steps are adjusted, and the other raw material components and the preparation steps are consistent. FIG. 2 is a schematic view of the product obtained in comparative example 4.
FIG. 2 (1) shows a product prepared by dispersing 9576Smooth Away Elastomer with cyclomethicone (comparative example 4); in FIG. 2, (2) shows the product obtained in example 4.
9576 the Smooth Away Elastomer material is white gel, and if the material is not dispersed uniformly in advance, the final product is layered, and the stability is poor. 9576 the dispersion effect of the Smooth Away Elastomer in the PMX-1503 silicone oil is excellent, and the finally prepared product has fine hand feeling and no granular feeling. The PMX-1503 silicone oil is a mixture of silicone oil and silica gel, and not only can well disperse the organic silicon elastomer, but also can increase the silky feeling of the product and further enhance the instant wrinkle-reducing effect of the eye cream.
And 9576Smooth Away Elastomer is difficult to disperse in common cyclomethicone, even if the dispersion is fully carried out by increasing the stirring time, the phenomenon of no stirring can still exist in the amplification production, so that the prepared product has particles, the stability of the product is influenced, and the phenomenon of drying and hardening of the paste can occur after long-term storage.
Test example 1: stability test
The eye creams prepared in the comparative example and the embodiment are respectively examined for stability performance, and the specific test method and the result are as follows:
the test method comprises the following steps: the paste with the weight of 40-50 g is filled into a 50mL transparent glass bottle, 6 parallel samples are respectively placed at the low temperature of-7 ℃, the low temperature of 4 ℃, the circulation of-7 ℃/45 ℃/24h, the high temperature of 45 ℃, the normal temperature of 25 ℃ and the investigation period of 30 days. Another sample was left at 60 ℃ and examined for 7 days.
And (3) stability judgment standard: the internal quality control standard is that after all samples are recovered to room temperature, compared with the samples at 4 ℃, the samples are stored at room temperature and circulated at high and low temperatures without obvious color change and odor change, the paste does not have layering phenomena such as water and oil discharge, and the paste is coated without particles or precipitates and is regarded as stable.
The specific results of the stability test are evaluated as shown in table 3 below:
table 3 stability test results of eye creams prepared by the comparative examples and examples
Figure BDA0003153941560000121
The test result shows that: the products prepared in the embodiments 1-5 of the invention have the advantages of fine hand feeling, no particles when being smeared, easy pushing, no abnormity in stability inspection and good product stability. The product prepared in the comparative example 3 can see particles by naked eyes and is coated with larger particles, and the ointment of the product obviously dries and hardens in the high-temperature 60 ℃, 45 ℃ and high-temperature and low-temperature cyclic test processes. The product prepared in comparative example 4 was visually observed for particles, coated with fine particles, and slightly delaminated during the high temperature cycle test at 60 ℃, 45 ℃ and high and low temperatures.
Test example 2: skin irritation test
The testing process comprises the following steps: the subjects were counted for 30 persons, and the specific gender and age were determined at random and were in accordance with the inclusion and exclusion criteria of "diagnostic criteria and treatment principles for cosmetic contact dermatitis".
Selecting qualified patch materials, selecting the samples prepared in example 1 and example 5 with the highest preservative content and the highest emulsifier content as representative samples, placing the representative samples into a patch tester, placing 10 holes in each example, wherein the dosage of the sample is 0.2g, and placing no substance in a control hole as a blank. The sample and blank control were applied to the curved side of the forearm of the subject and gently pressed with the palm of the hand to apply evenly to the skin for 24 hours. Removing the patch applicator, keeping the interval for 30min, and observing skin reaction after the indentation disappears. The skin reaction was observed once more 24h and 48h after patch test, respectively.
And (3) judging standard: according to the classification judgment of the cosmetic contact dermatitis diagnosis standard and the treatment principle, the non-reaction of the tested part is (0), the light erythema of the skin is (1), the erythema, infiltration or papule of the skin is (2), the edematous erythema and papule of the skin are (3), and the remarkable redness, swelling accompanied by papule or bulla of the skin is (4).
In 30 cases, the number of people with grade 2 adverse reactions on skin is more than 2, or any 1 case with grade 3 or more than 3 adverse reactions on skin, and the tested substance is judged to have adverse reactions on human body.
The specific results are evaluated as follows, and the results of the 0.5h spot removal test are shown in the following table 4:
table 4 skin irritation test results
Figure BDA0003153941560000131
The test result shows that: the result of the patch test in the test is judged that the eye cream prepared by the invention has no adverse reaction on human skin according to the requirement of 2015 cosmetic hygiene standard.
Test example 3: evaluation of instant lightening and wrinkle-reducing efficacy
And carrying out consumer trial effect test on the samples obtained in the examples and the comparative examples, and carrying out photo comparison and evaluation by experts and consumer self evaluation.
The specific test method comprises the following steps: 160 volunteers with fine lines and black circles on eye skin are recruited together, the gender is random, the age is 18-55 years, 20 volunteers are randomly selected from each experimental group, the volunteers are required to take pictures around the eyes before sample trial and are filed, then samples provided by the mung bean-sized embodiment and the comparative example are respectively taken and are smeared around the eyes of a tested person, facial images are taken after 3min and are filed, and the instant brightening and lightening effect of the light lines is observed.
And (3) testing conditions are as follows: an indoor environment; the environmental temperature is 20 plus or minus 2 ℃, the environmental humidity is 40-60 percent, and strong sunlight or direct light is not generated.
And (3) judging standard: the visual improvement of the fine lines of the eyes is regarded as the instant light lines of the sample are effective; the sample is regarded as effective in immediately brightening when the eye dark circles become lighter by naked eyes.
The invention adopts VISIA-CR (CANFIELD, America) to shoot facial images, the instrument combines the most advanced digital photography technology, and has a plurality of light sources (standard light, UV light, cross polarized light and parallel polarized light), thereby improving the visual degree of skin analysis. The invention is shown in fig. 3, which is a comparison chart of the outside of the eye of a tested person of a sample of example 4 taken by using a VISIA-CR Standard 2 light source mode.
The results of the experts, by comparing the photos before and after the product is tried, evaluating and feeding back the effective rate of the instant light lines and the effective rate of the instant brightening are summarized as the following table 5:
TABLE 5 instant brightening and lightening stripe efficacy expert evaluation results
Figure BDA0003153941560000132
Figure BDA0003153941560000141
The results of analyzing the consumer questionnaire and feeding back the trial results, and evaluating the feedback to obtain the effective rate of the consumer's immediate light streaking and the effective rate of the consumer's immediate brightening are summarized in the following table 6:
TABLE 6 consumer evaluation results of instant lightening and wrinkle-reducing efficacy
Group of Effective rate of instant wrinkle reduction Instant effective rate of brightening
Example 1 90% 95%
Example 2 85% 90%
Example 3 90% 95%
Example 4 95% 100%
Example 5 85% 95%
Comparative example 1 85% 40%
Comparative example 2 65% 90%
Eye cream sold on market 50% 40%
From the test results, the instant brightening and wrinkle-reducing eye cream prepared by the invention can effectively provide instant brightening efficacy for improving black eye circles and instant wrinkle-reducing efficacy for improving fine wrinkles, and additionally provides perceptible instant smoothing efficacy, and is obviously superior to the common moisturizing eye cream in the existing market. In addition, as can be seen from fig. 3, after the eye cream of the present invention is tried by a subject, fine wrinkles of the eyes are obviously improved, and the eye cream has a good instant wrinkle-fading effect.
In conclusion, the raw materials of the instant brightening and wrinkle-reducing eye cream comprise a plurality of active ingredients such as nicotinamide, borneol, pearl extract, ligusticum wallichii root extract, poria cocos sclerotium extract, bighead atractylodes rhizome root extract, rhizoma bletillae extract, radix ampelopsis extract, artificial bezoar and rosa damascena flower water, the instant lightening wrinkles are achieved by adding full-acetylated sodium hyaluronate, 4D hyaluronic acid, acetyl octapeptide-3, gleditsia sinensis seed extract, 9576Smooth Away Elastomer deep water replenishing and filling skin, film forming and tightening Smooth skin, soft focus factor filling skin and muscle contraction inhibiting and the like through multi-dimensional combination of the effective ingredients, and the instant brightening ingredient comprises
Figure BDA0003153941560000142
The Halo White physical concealer immediately brightens the skin around the eyes. The eye moisturizing cream provided by the invention can provide basic water replenishing, moisturizing and moistening for the skin around the eyes, can achieve the effects of immediately brightening the skin around the eyes and immediately fading lines around the eyes, has a good immediate effect, and is suitable for long-term use.
The present invention is illustrated by the above examples, but the present invention is not limited to the above examples, i.e. it is not intended that the present invention is implemented only by the above examples. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitution of individual materials for the product of the present invention and addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.

Claims (8)

1. The eye cream with the effect of immediately brightening and lightening wrinkles is characterized by comprising the following preparation raw materials in parts by weight:
Figure FDA0003574389290000011
wherein the instant light grain component comprises, by weight, 0.01-1 part of acetylated sodium hyaluronate, 0.1-5 parts of acetyl octapeptide-3, 1-5 parts of 4D hyaluronic acid, 0.1-3 parts of gleditsia sinensis seed extract and 1-10 parts of an organic silicon elastomer;
wherein the silicone Elastomer is 9576 smoothen Away Elastomer;
wherein the silicone elastomer is dispersed in advance with PMX-1503 silicone oil to be particle-free at the time of use.
2. The eye cream with instant brightening and wrinkle-reducing effects of claim 1, wherein said instant brightening component is
Figure FDA0003574389290000012
Halo White。
3. The eye cream with instant lightening and wrinkle reducing effects as claimed in claim 1, wherein the emulsifier is one or both of SIMULSOL165 and MONTANOV 68.
4. The eye cream with the effect of immediately brightening and wrinkle reducing as claimed in claim 3, wherein the other active substances comprise, by weight, 0.1-5 parts of niacinamide, 0.001-0.1 part of borneol, 0.01-1 part of pearl extract, 0.01-0.2 part of chuanxiong rhizome extract, 0.001-0.1 part of poria cocos sclerotium extract, 0.001-0.1 part of atractylodes macrocephala koidz root extract, 0.001-0.5 part of bletilla striata extract, 0.001-0.1 part of ampelopsis japonica root extract, 0.0001-0.002 part of calculus bovis factitius and 1-10 parts of rosa damascena flower water.
5. The eye cream with the effect of immediately brightening and frizziness as claimed in claim 4, wherein the raw materials for preparation further comprise 1-5 parts of Shuyijia.
6. The eye cream with the effect of immediately brightening and wrinkle reducing according to claim 5, characterized in that the raw materials for preparation further comprise 0.1-5 parts of a skin-care agent.
7. The eye cream with the effect of immediately brightening and line lightening as claimed in claim 6, wherein the raw materials for preparation further comprise 0.1-1 part of preservative and 0.001-0.1 part of essential oil.
8. A method for preparing the eye cream with the effect of immediately brightening and lightening the wrinkles as claimed in any one of claims 1 to 7, which comprises the following steps:
s1, adding glycerol, EDTA disodium, Sumingjia, 4D hyaluronic acid, p-hydroxyacetophenone, 1, 2-hexanediol and sodium surfactin into deionized water, heating to 75-85 ℃, and preserving heat for 5-30min to obtain a mixture A1 phase;
s2, adding the pearl extract, the ligusticum wallichii root extract, the poria cocos sclerotium extract, the bighead atractylodes rhizome root extract, the bletilla striata extract, the radix ampelopsis extract and the polysorbate-20 into deionized water, then adding propylene glycol with borneol and calculus bovis factitius dissolved in the deionized water, heating and dispersing the mixture uniformly, and then sieving the mixture through a 200-mesh sieve to obtain a mixture A2 phase;
s3, adding the mixture A2 phase into the mixture A1 phase, uniformly stirring to obtain a mixture A phase, and preserving heat at 75-85 ℃;
s4, dispersing the organic silicon elastomer by PMX-1503 silicone oil in advance until no particles exist to obtain a mixture B1 phase;
s5, uniformly mixing polydimethylsiloxane, phenyl trimethicone and an emulsifier, heating to 75-85 ℃ to obtain a B2 phase, adding the B1 phase of the mixture obtained in the step S4, uniformly stirring, and keeping the temperature for 5-30min to obtain a B phase of the mixture;
s6, dispersing the SEPINOV EMT10 thickening agent with butanediol at room temperature to obtain a mixture C phase;
s7, uniformly dispersing the instant brightening component at room temperature by using the residual butanediol in the formula to obtain a mixture D phase;
s8, dissolving acetyl octapeptide-3, skin-friendly agent, nicotinamide, Rosa damascena flower water, Gleditsia sinensis seed extract and sodium hyaluronate with deionized water at room temperature to obtain mixture phase E;
s9, adding the mixture B phase after heat preservation into the mixture A phase, adding the mixture C phase at the same time, keeping the temperature at 75-85 ℃, vacuumizing, keeping high-speed homogenizing and stirring for 5-30min, and obtaining a first mixed phase;
s10, cooling the first mixed phase obtained in the step S9 to 50-60 ℃, adding the mixture D phase obtained in the step S7, and keeping high-speed homogenizing and stirring for 1-30 min to obtain a second mixed phase;
s11, cooling the second mixed phase obtained in the step S10 to 40-50 ℃, adding the phase E of the mixture obtained in the step S8, and keeping high-speed homogenizing and stirring for 1-30 min to obtain a third mixed phase;
s12, cooling the third mixed phase obtained in the step S11 to be below 40 ℃, adding a preservative, a pH regulator and essential oil, regulating the pH to be 5.5-7.5, and stirring for 10-30 min to obtain the eye cream with the effect of immediately brightening and lightening wrinkles.
CN202110771890.6A 2021-07-08 2021-07-08 Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof Active CN113413355B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110771890.6A CN113413355B (en) 2021-07-08 2021-07-08 Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110771890.6A CN113413355B (en) 2021-07-08 2021-07-08 Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113413355A CN113413355A (en) 2021-09-21
CN113413355B true CN113413355B (en) 2022-05-27

Family

ID=77720477

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110771890.6A Active CN113413355B (en) 2021-07-08 2021-07-08 Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113413355B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115317429B (en) * 2022-08-30 2023-05-26 马应龙大健康有限公司 Composition containing recombinant collagen and having repairing and relieving effects, eye cream containing composition, preparation method and application
CN115300433B (en) * 2022-09-16 2024-02-09 湖北马应龙生物科技有限公司 Eye mask essence with whitening and repairing effects and preparation method and application thereof
CN115778831B (en) * 2022-12-09 2024-01-09 上海臻臣化妆品有限公司 Oil-in-water type brightening liquid and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1507342A (en) * 2001-05-10 2004-06-23 宝洁公司 Cosmetic composition conprising silicone elastomer
DE10311302A1 (en) * 2003-03-14 2004-09-23 Beiersdorf Ag Decorative cosmetic products with effect pigments
WO2015166448A1 (en) * 2014-04-30 2015-11-05 L'oreal Composition comprising microcapsules containing silicone elastomer
CN106714773A (en) * 2014-09-25 2017-05-24 莱雅公司 Emulsion comprising a silicone-based dendritic film-forming polymer and a pasty compound, treatment process using the same and suitable device
CN110139637A (en) * 2016-12-28 2019-08-16 Lvmh研究公司 Cosmetic composition with general optical correction
CN112675076A (en) * 2021-01-04 2021-04-20 上海新高姿化妆品有限公司 Cosmetic composition for brightening skin color and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108882951B (en) * 2016-02-12 2022-01-11 罗丹菲尔茨有限责任公司 Moisturizing composition and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1507342A (en) * 2001-05-10 2004-06-23 宝洁公司 Cosmetic composition conprising silicone elastomer
DE10311302A1 (en) * 2003-03-14 2004-09-23 Beiersdorf Ag Decorative cosmetic products with effect pigments
WO2015166448A1 (en) * 2014-04-30 2015-11-05 L'oreal Composition comprising microcapsules containing silicone elastomer
CN106714773A (en) * 2014-09-25 2017-05-24 莱雅公司 Emulsion comprising a silicone-based dendritic film-forming polymer and a pasty compound, treatment process using the same and suitable device
CN110139637A (en) * 2016-12-28 2019-08-16 Lvmh研究公司 Cosmetic composition with general optical correction
CN112675076A (en) * 2021-01-04 2021-04-20 上海新高姿化妆品有限公司 Cosmetic composition for brightening skin color and preparation method and application thereof

Also Published As

Publication number Publication date
CN113413355A (en) 2021-09-21

Similar Documents

Publication Publication Date Title
CN113413355B (en) Eye cream with instant brightening and wrinkle reducing effects and preparation method thereof
CN101590003B (en) Whitening spot-relieving cream cosmetic and preparation method thereof
CN109568215B (en) Moisturizing and moisturizing repair essence cream containing soluble beeswax and preparation method thereof
CN102641228B (en) Rhodiola crenulata eye cream with whitening and anti-wrinkle effects
CN106176511B (en) A kind of propolis pore cleanser nose film and its preparation method and application
CN107898660A (en) A kind of tender skin water light stoste and its preparation method and application
CN104027271B (en) Emulsion and preparation method thereof
CN111939116A (en) Anti-aging composition and preparation method thereof
CN110664650A (en) Multi-effect skin care composition and essence and preparation method thereof
CN102641233A (en) Rhodiola crenulata facial mask with whitening and moisturizing effects
CN107468582A (en) One kind is compacted anti-wrinkle eye shadow and preparation method thereof
CN109498538B (en) Composition, cosmetic and essence with moisturizing and whitening effects and preparation method thereof
CN110585048A (en) Composition with anti-saccharification and anti-oxidation functions and application thereof
CN110859795A (en) Freckle-removing and anti-aging composition, preparation method thereof and facial mask pearl powder
CN113576975A (en) Easily-absorbed anti-aging composition and preparation method and application thereof
CN110037976B (en) Moisturizing and anti-inflammatory composition and skin care product
CN106619223A (en) Natural anti-aging cosmetic and preparation method thereof
CN105708759A (en) Pure natural antioxidant whitening multi-effect face cream with peony seed oil and preparation method thereof
CN115317385B (en) Foundation composition and preparation method thereof
CN111728912A (en) Moisturizing and allergy-relieving essence face cream and preparation method thereof
CN111450017A (en) Beautifying essence containing fullerene and preparation method thereof
CN111110624A (en) Whitening composition
CN112022763A (en) Liquid foundation and preparation method thereof
CN111150682A (en) Sparassis crispa antioxidant whitening face cream
KR20120106475A (en) Functional cosmetic composition including herb medicine extract

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant